|Bid||553.43 x 900|
|Ask||555.55 x 1100|
|Day's range||552.16 - 558.20|
|52-week range||441.00 - 686.62|
|Beta (5Y monthly)||0.16|
|PE ratio (TTM)||15.75|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||677.04|
Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.
Both of these companies are reporting earnings within the next month, and there could be a dip in price that follows.